Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 9 de 9
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Biochem Biophys Res Commun ; 528(3): 499-505, 2020 07 30.
Article de Anglais | MEDLINE | ID: mdl-32513534

RÉSUMÉ

Measuring glucose uptake in the skeletal muscle in vivo is an effective method to determine glucose metabolism abnormalities as the skeletal muscle is the principal tissue responsible for glucose disposal and is a major site of peripheral insulin resistance. In this study, we investigated the pathological glucose metabolism dynamics of the skeletal muscle of C57BL/6J mice in a noninvasive and time-sequential manner using positron emission tomography/computed tomography (PET/CT), an imaging technique that uses radioactive substances to visualize and measure metabolic processes in the body, with [18F]-fluoro-2-deoxy-D-glucose (FDG). FDG-PET/CT imaging revealed that insulin administration and exercise load significantly increased FDG accumulation in the skeletal muscle of C57BL/6J mice. FDG accumulation was lower in the skeletal muscle of 14-week-old db/db diabetic model mice exhibiting remarkable insulin resistance compared to that of 7-week-old db/db mice. Based on the continuous observation of FDG accumulation over time in diet-induced obese (DIO) mice, FDG accumulation significantly decreased in 17-week-old mice after the acquisition of insulin resistance. Although insulin-induced glucose uptake in the skeletal muscle was markedly attenuated in 20-week-old DIO mice that had already developed insulin resistance, exercise load effectively increased FDG uptake in the skeletal muscle. Thus, we successfully confirmed that glucose uptake accompanied by insulin administration and exercise load increased in the skeletal muscle using PET-CT. FDG-PET/CT might be an effective tool that could noninvasively capture the chronological changes of metabolic abnormalities in the skeletal muscle of mice.


Sujet(s)
Insulinorésistance/physiologie , Muscles squelettiques/imagerie diagnostique , Muscles squelettiques/métabolisme , Animaux , Diabète expérimental/imagerie diagnostique , Diabète expérimental/métabolisme , Alimentation riche en graisse/effets indésirables , Fluorodésoxyglucose F18 , Glucose/métabolisme , Mâle , Souris , Souris de lignée C57BL , Souches mutantes de souris , Obésité/imagerie diagnostique , Obésité/étiologie , Obésité/métabolisme , Effort physique/physiologie , Tomographie par émission de positons couplée à la tomodensitométrie , Radiopharmaceutiques
2.
PLoS One ; 15(5): e0233390, 2020.
Article de Anglais | MEDLINE | ID: mdl-32437400

RÉSUMÉ

Hypertrophy, associated with adipocyte dysfunction, causes increased pro-inflammatory adipokine, and abnormal glucose and lipid metabolism, leading to insulin resistance and obesity-related-health problems. By combining DNA microarray and genomic data analyses to predict DNA binding motifs, we identified the transcription factor Interferon Regulatory Factor 7 (IRF7) as a possible regulator of genes related to adipocyte hypertrophy. To investigate the role of IRF7 in adipocytes, we examined gene expression patterns in 3T3-L1 cells infected with a retrovirus carrying the IRF7 gene and found that enforced IRF7 expression induced the expression of monocyte chemoattractant protein-1 (MCP-1), a key initial adipokine in the chronic inflammation of obesity. CRISPR/Cas9 mediated-suppression of IRF7 significantly reduced MCP-1 mRNA. Luciferase assays, chromatin immunoprecipitation PCR analysis and gel shift assay showed that IRF7 transactivates the MCP-1 gene by binding to its proximal Interferon Stimulation Response Element (ISRE), a putative IRF7 binding motif. IRF7 knockout mice exhibited lower expression of MCP-1 in epidydimal white adipose tissue under high-fat feeding conditions, suggesting the transcription factor is physiologically important for inducing MCP-1. Taken together, our results suggest that IRF7 transactivates MCP-1 mRNA in adipocytes, and it may be involved in the adipose tissue inflammation associated with obesity.


Sujet(s)
Adipocytes/métabolisme , Chimiokine CCL2/génétique , Facteur-7 de régulation d'interféron/génétique , Obésité/génétique , Cellules 3T3-L1 , Tissu adipeux blanc/métabolisme , Animaux , Chimiokine CCL2/métabolisme , Régulation de l'expression des gènes , Cellules HEK293 , Humains , Facteur-7 de régulation d'interféron/métabolisme , Souris , Souris knockout , Obésité/métabolisme , Régions promotrices (génétique)
3.
J Med Invest ; 67(1.2): 51-61, 2020.
Article de Anglais | MEDLINE | ID: mdl-32378618

RÉSUMÉ

Spontaneously Running Tokushima Shikoku (SPORTS) rat is a hyperactive rat strain. However, the causative mutation of this phenotype has not yet been identified. To investigate the molecular basis for the unique phenotype of SPORTS rats, we examined gene-expression profiles by microarray analyses. Among adenylate kinase isozymes that maintain the homeostasis of cellular adenine nucleotide composition in the cell, only adenylate kinase 1 is highly up-regulated in both exercised and sedentary SPORTS rats compared with wild-type (WT) rats, 5.5-fold and 3.3-fold, respectively. Further comparative analyses revealed that genes involved in glucose metabolism were up-regulated in skeletal muscle tissue of exercised SPORTS rats compared with sedentary mutants, whereas genes related to extracellular matrix or region were down-regulated compared with WT rats. In brain tissue of sedentary SPORTS rats, genes associated with defense and catecholamine metabolism were highly expressed compared with WT rats. These findings suggest that genetic mutation(s) in SPORTS rat remodels metabolic demands through differentially regulating gene expression regardless of exercise. Therefore, the SPORTS rats are useful animal model not only for further examining the effects of exercise on metabolism but also for deeply studying the molecular basis how mutation affect the psychological motivation with spontaneous voluntary exercise phenotype. J. Med. Invest. 67 : 51-61, February, 2020.


Sujet(s)
Hypercinésie/génétique , Conditionnement physique d'animal , Transcriptome , Adenylate kinase/génétique , Animaux , Mâle , Transporteurs d'acides monocarboxyliques/génétique , Muscles squelettiques/métabolisme , Mutation , Phénotype , Rats , Rat Wistar
4.
J Muscle Res Cell Motil ; 41(2-3): 199-209, 2020 09.
Article de Anglais | MEDLINE | ID: mdl-32451822

RÉSUMÉ

ACTN2 and ACTN3 encode sarcomeric α-actinin-2 and α-actinin-3 proteins, respectively, that constitute the Z-line in mammalian skeletal muscle fibers. In human ACTN3, a nonsense mutation at codon 577 that encodes arginine (R) produces the R577X polymorphism. Individuals having a homozygous 577XX genotype do not produce α-actinin-3 protein. The 577XX genotype reportedly occurs in sprint and power athletes in frequency lower than in the normal population, suggesting that α-actinin-3 deficiency diminishes fast-type muscle function. Among humans who carry 577R alleles, varying ACTN3 expression levels under certain conditions can have diverse effects on atheletic and muscle performance. However, the factors that regulate ACTN3 expression are unclear. Here we investigated whether the unfolded protein response (UPR) under endoplasmic reticulum (ER) stress regulates expression of Actn3 and its isoform Actn2 in mouse C2C12 myotubes. Among UPR-related transcription factors, XBP1 upregulated Actn2, whereas XBP1, ATF4 and ATF6 downregulated Actn3 promoter activity. Chemical induction of ER stress increased Actn2 mRNA levels, but decreased those for Actn3. ER stress also decreased α-actinin-3 protein levels, whereas levels of α-actinin-2 were unchanged. The intracellular composition of muscle contraction-related proteins was altered under ER stress, in that expression of parvalbumin (a fast-twitch muscle-specific protein) and troponin I type 1 (skeletal, slow) was suppressed. siRNA-induced suppression of Actn3 mimicked the inhibitory effect of ER stress on parvalbumin levels. Thus, endogenous expression levels of α-actinin-3 can be altered by ER stress, which may modulate muscle performance and athletic aptitudes, particularly in humans who carry ACTN3 577R alleles.


Sujet(s)
Actinine/biosynthèse , Fibres musculaires squelettiques/métabolisme , Réponse aux protéines mal repliées/génétique , Actinine/génétique , Actinine/métabolisme , Animaux , Biologie informatique/méthodes , Humains , Souris , Fibres musculaires squelettiques/cytologie , Transfection
5.
Biochem Biophys Res Commun ; 514(1): 166-172, 2019 06 18.
Article de Anglais | MEDLINE | ID: mdl-31029425

RÉSUMÉ

Orexin is known as an important neuropeptide in the regulation of energy metabolism. However, the role of orexin in exercise-induced leptin sensitivity in the hypothalamus has been unclear. In this study, we determined the effect of transient treadmill exercise on leptin sensitivity in the mediobasal hypothalamus (MBH) of mice and examined the role of orexin in post-exercise leptin sensitivity. Treadmill running for 45 min increased the orexin neuron activity in mice. Intraperitoneal injection of a submaximal dose of leptin after exercise stimulated the phosphorylation of signal transducer and activator of transcription 3 (STAT3) in MBH of mice post-exercise compared with that in non-exercised mice, although intracerebroventricular (icv) injection of leptin did not enhance STAT3 phosphorylation, even after exercise. Icv injection of an orexin receptor antagonist, SB334867 reduced STAT3 phosphorylation, which was enhanced by icv injection of orexin but not by direct injection of orexin into MBH. Exercise increased the phosphorylation of extracellular signal-regulated kinases (ERKs) in the MBH of mice, while ERK phosphorylation was reduced by SB334867. Leptin injection after exercise increased the leptin level in MBH, whereas icv injection of SB334867 suppressed the increase in the leptin level in MBH of mice. These results indicate that the activation of orexin neurons by exercise may contribute to the enhancement of leptin sensitivity in MBH. This effect may be mediated by increased transportation of circulating leptin into MBH, with the involvement of ERK phosphorylation.


Sujet(s)
Hypothalamus/physiologie , Leptine/pharmacologie , Orexines/métabolisme , Animaux , Benzoxazoles/pharmacologie , Épreuve d'effort , Hypothalamus/effets des médicaments et des substances chimiques , Mâle , Souris de lignée C57BL , Naphtyridines/pharmacologie , Neurones/effets des médicaments et des substances chimiques , Antagonistes des récepteurs des orexines/pharmacologie , Récepteurs des orexines/métabolisme , Orexines/pharmacologie , Phosphorylation , Conditionnement physique d'animal , Récepteurs à la leptine/métabolisme , Facteur de transcription STAT-3/métabolisme , Urée/analogues et dérivés , Urée/pharmacologie
6.
Biochem Biophys Res Commun ; 502(3): 422-428, 2018 07 20.
Article de Anglais | MEDLINE | ID: mdl-29857001

RÉSUMÉ

The ACTN3 gene encodes α-actinin-3 protein, which stabilizes the contractile apparatus at the Z-line in skeletal muscle cell fast fibers. A nonsense mutation of the arginine (R) at the codon for amino acid 577 of the ACTN3 gene generates a premature termination codon (PTC) and produces the R577X polymorphism in humans (X specifies translational termination). The ACTN3 577X genotype abolishes α-actinin-3 protein production due to targeted degradation of the mutant transcript by the cellular nonsense-mediated mRNA decay (NMD) system, which requires mRNA splicing. In humans, α-actinin-3 deficiency can decrease sprinting and power performance as well as skeletal muscle mass and strength. Here we investigated whether suppression of the in-frame PTC induced by treatment with the aminoglycosides gentamicin and G418 that promote termination codon readthrough could allow production of full-length α-actinin-3 protein from ACTN3 577X. We constructed expression plasmids encoding mature mRNA that lacks introns or pre-mRNA, which carries introns for the ACTN3 577X gene (X and Xpre, respectively) and transfected the constructs into HEK293 cells. Similar constructs for the ACTN3 577R gene were used as controls. HEK293 cells carrying the X gene, but not the Xpre gene, expressed exogenous truncated α-actinin-3 protein, indicating NMD-mediated suppression of exogenous Xpre expression. Cells treated with aminoglycosides produced exogenous full-length α-actinin-3 protein in X-transfected cells, but not in Xpre-transfected cells. The NMD inhibitor caffeine prevented suppression of Xpre expression and thereby induced production of full-length α-actinin-3 protein in the presence of aminoglycoside. Together these results indicate that the ACTN3 R577X polymorphism could be a novel target for readthrough therapy, which may affect athletic and muscle performance in humans.


Sujet(s)
Actinine/biosynthèse , Actinine/génétique , Codon non-sens , Protéines mutantes/biosynthèse , Protéines mutantes/génétique , Caféine/pharmacologie , Codon non-sens/effets des médicaments et des substances chimiques , Gentamicine/pharmacologie , Cellules HEK293 , Humains , Muscles squelettiques/métabolisme , Terminaison de la traduction/effets des médicaments et des substances chimiques , Stabilité de l'ARN , ARN messager/génétique , ARN messager/métabolisme , Transfection
7.
Peptides ; 87: 12-19, 2017 01.
Article de Anglais | MEDLINE | ID: mdl-27825986

RÉSUMÉ

There is an increasing interest in elucidating the molecular mechanisms by which voluntary exercise is regulated. In this study, we examined how the central nervous system regulates exercise. We used SPORTS rats, which were established in our laboratory as a highly voluntary murine exercise model. SPORTS rats showed lower levels of serum ghrelin compared with those of the parental line of Wistar rats. Intracerebroventricular and intraperitoneal injection of ghrelin decreased wheel-running activity in SPORTS rats. In addition, daily injection of the ghrelin inhibitor JMV3002 into the lateral ventricles of Wistar rats increased wheel-running activity. Co-administration of obestatin inhibited ghrelin-induced increases in food intake but did not inhibit ghrelin-induced suppression of voluntary exercise in rats. Growth hormone secretagogue receptor (GHSR) in the hypothalamus and hippocampus of SPORTS rats was not difference that in control rats. We created an arcuate nucleus destruction model by administering monosodium glutamate (MSG) to neonatal SPORTS rats. Injection of ghrelin into MSG-treated rats decreased voluntary exercise but did not increase food intake, suggesting that wheel-running activity is not controlled by the arcuate nucleus neurons that regulate feeding. These results provide new insights into the mechanism by which ghrelin regulates voluntary activity independent of arcuate nucleus neurons.


Sujet(s)
Ghréline/métabolisme , Activité motrice/effets des médicaments et des substances chimiques , Conditionnement physique d'animal , Course à pied/physiologie , Animaux , Noyau arqué de l'hypothalamus/effets des médicaments et des substances chimiques , Noyau arqué de l'hypothalamus/métabolisme , Consommation alimentaire/effets des médicaments et des substances chimiques , Ghréline/administration et posologie , Perfusions intraventriculaires , Activité motrice/physiologie , Neurones/effets des médicaments et des substances chimiques , Neurones/métabolisme , Rats , Rat Wistar , Glutamate de sodium/administration et posologie
8.
PLoS One ; 11(8): e0160532, 2016.
Article de Anglais | MEDLINE | ID: mdl-27494408

RÉSUMÉ

Leptin is a key regulator of energy intake and expenditure. This peptide hormone is expressed in mouse white adipose tissue, but hardly expressed in 3T3-L1 adipocytes. Using bisulfite sequencing, we found that CpG islands in the leptin promoter are highly methylated in 3T3-L1cells. 5-azacytidine, an inhibitor of DNA methyltransferase, markedly increased leptin expression as pre-adipocytes matured into adipocytes. Remarkably, leptin expression was stimulated by insulin in adipocytes derived from precursor cells exposed to 5-azacytidine, but suppressed by thiazolidinedione and dexamethasone. In contrast, adipocytes derived from untreated precursor cells were unresponsive to both 5-azacytidine and hormonal stimuli, although lipid accumulation was sufficient to boost leptin expression in the absence of demethylation. Taken together, the results suggest that leptin expression in 3T3-L1 cells requires DNA demethylation prior to adipogenesis, transcriptional activation during adipogenesis, and lipid accumulation after adipogenesis.


Sujet(s)
Adipocytes/physiologie , Méthylation de l'ADN , Leptine/génétique , Cellules 3T3-L1/effets des médicaments et des substances chimiques , Animaux , Azacitidine/pharmacologie , DNA (Cytosine-5-)-methyltransferase 1 , DNA (cytosine-5-)-methyltransferase/génétique , DNA (cytosine-5-)-methyltransferase/métabolisme , Méthylation de l'ADN/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Leptine/métabolisme , Mâle , Souris , Souris de lignée C57BL , Obésité/métabolisme , Régions promotrices (génétique)
9.
J Med Invest ; 62(3-4): 199-203, 2015.
Article de Anglais | MEDLINE | ID: mdl-26399348

RÉSUMÉ

Enhancing exercise motivation is the best way to prevent obesity and diabetes. In this study, we examined whether adiponectin affects locomotion activity in Wister and Spontaneously-Running Tokushima-Shikoku (SPORTS) rats using two types of behavioral assays: home cage and wheel running activity. SPORTS rats were established from an original line from Wister strain that had shown high level of wheel running activity in our laboratory. Injection of adiponectin into the lateral ventricle of Wister rats and SPORTS rats decreased home cage activity, but no change was observed in the food intake and oxygen consumption. This result indicates the possibility that adiponectin can reduce non-exercise activity thermogenesis (NEAT) and physical activity via the central nervous system. In contrast, injection of adiponectin did not change wheel running activity in SPORTS rats. We produced hypothalamus-destructed model rat using monosodium glutamate (MSG) to elucidate the regulation site of adiponectin. Injection of adiponectin into MSG-treated SPORTS rats did not change amount of home cage activity and food intake, suggesting that adiponectin action on home cage activity was in the hypothalamic area. These results suggest that adiponectin regulates locomotion activity through mediobasal hypothalamus.


Sujet(s)
Adiponectine/pharmacologie , Hypothalamus/effets des médicaments et des substances chimiques , Activité motrice/effets des médicaments et des substances chimiques , Adiponectine/administration et posologie , Animaux , Hypothalamus/physiologie , Injections ventriculaires , Mâle , Rats , Rat Wistar , Glutamate de sodium/pharmacologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...